Home / Stocks / Laxmi Dental Limited
LAXMIDENTL

Laxmi Dental Limited Share Price

Live price, chart and which mutual funds hold this stock

…

as of —

₹—

Change

—

Day Open

₹—

Day High

₹—

Day Low

₹—

NSE Close — 19 Nov 2026

₹192.56

Change

-2.83 (-1.45%)

Open

₹196.31

Prev. Close

₹195.39

Day High

₹197.57

Day Low

₹191.6

Volume Analysis

Traded

36,645

Delivered

24,071

Delivery %

65.69%

End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.

Strengths, Weaknesses, Opportunities & Threats

Strengths (0)

No signal for this stock

Weaknesses (0)

No signal for this stock

Opportunities (1)

  • •Strong 3-year revenue growth (19.7%)

Threats (1)

  • •FII holding has been falling

Rule-based signals from the fundamentals below — not investment advice.

Pivot Levels

Type R3 R2 R1 Pivot S1 S2 S3
Classic ₹202.19 ₹199.88 ₹196.22 ₹193.91 ₹190.25 ₹187.94 ₹184.28
Fibonacci ₹199.88 ₹197.6 ₹196.19 ₹193.91 ₹191.63 ₹190.22 ₹187.94
Camarilla ₹194.2 ₹193.65 ₹193.11 ₹193.91 ₹192.01 ₹191.47 ₹190.92

Support/resistance levels for today, calculated from the previous trading day's high/low/close.

Absolute Returns

YTD

-29.91%

1 Week

-6.78%

1 Month

+8.2%

3 Months

-2.82%

6 Months

-22.75%

1 Year

-34.69%

2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.

Stock Vitals

Computed from the latest available annual financials.

Graham Number

₹75.52

Current price is above the Graham Number — Benjamin Graham's estimate of fair value based on earnings and book value.

DuPont ROE Breakdown

11.39%

Net margin 10.88% × asset turnover 0.88x × equity multiplier 1.19x

Company Overview

Sector

Healthcare

Market Cap

₹1,076 Cr

P/E (TTM)

29.7

ROE

14.8%

Book Value

₹48.1

Face Value

₹2.0

Source: Screener.in (Consolidated figures) — data as of 18 Nov 2026. Not investment advice.

TopFund Analysis

Laxmi Dental Limited lands in the middle of the pack on TopFund's composite fundamentals check within the Healthcare sector, at 55/100. The strongest factor is Financial Strength (100/100), while Cash Flow (0/100) is the weakest area to weigh before deciding. FII holding has been falling.

TopFund Score — Fundamentals Quality

55/100 — Average

Data confidence: 77/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.

As of 19 Nov 2026 · How we calculate this →

Financial Strength

100

Growth

99

Valuation

44

Cash Flow

0

Corporate Governance

56

Momentum

26

Institutional Ownership

23

Business Quality

68

Risk & Volatility

30

Liquidity

37

From Screener.in

  • +Company has reduced debt.
  • +Company is almost debt free.
  • +Company has delivered good profit growth of 103% CAGR over last 5 years
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −Tax rate seems low
  • −Working capital days have increased from 72.9 days to 182 days

Not investment advice — an automated read of public fundamentals data, for research context only.

Corporate Actions

Extract of newspaper advertisements published on November 05, 2026, in the Financial Express (English Newspaper) and Mumbai Lakshdeep (Marathi Newspaper), with respect to Unaudited Standalone …

Audio recording of Q2FY27 and H1FY27 earnings conference call uploaded on company website.

Laxmi Dental reported Q2 FY27 revenue of ₹79.5 crore and PAT of ₹10.0 crore; H1 revenue ₹154.2 crore.

Source: BSE regulatory filings, via Screener.in.

Quarterly Results

Last several quarters

  Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Sales + 48 55 60 57 62 61 66 72 66 74 75 80
Expenses + 44 43 46 48 52 51 54 61 59 60 60 64
Operating Profit 4 12 14 9 10 10 12 11 7 14 14 15
OPM % 8.0% 21.0% 23.0% 15.0% 16.0% 16.0% 18.0% 15.0% 11.0% 18.0% 19.0% 19.0%
Other Income + 0 0 6 1 1 2 2 2 -4 2 2 2
Interest 1 1 1 1 2 1 0 0 0 0 0 0
Depreciation 3 3 3 3 4 4 4 4 4 4 4 5
Profit before tax -1 7 16 5 5 6 10 9 -1 11 12 12
Tax % -140.0% 16.0% 11.0% 23.0% 23.0% 41.0% 24.0% 20.0% -175.0% 4.0% 21.0% 19.0%
Net Profit + 2 8 17 6 5 4 8 9 2 10 10 10
EPS in Rs 0 1 3 1 1 1 2 2 0 2 2 2
Raw PDF — — — — — — — — — — — —
YoY Sales growth — — — — 29 10 10 27 7 22 14 10

Source: Screener.in — figures in ₹ Crores unless marked %.

Profit & Loss (Yearly)

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 TTM
Sales + 150 92 137 162 194 239 278 294
Expenses + 146 88 130 152 169 196 234 244
Operating Profit 3 4 7 9 24 43 44 50
OPM % 2.3% 4.6% 4.8% 6.0% 13.0% 18.0% 16.0% 17.0%
Other Income + 2 0 -10 2 0 10 3 3
Interest 3 3 4 4 6 6 2 1
Depreciation 7 6 8 11 12 15 16 18
Profit before tax -4 -4 -16 -5 7 31 29 34
Tax % 5.0% 8.0% 15.0% 4.0% -136.0% 21.0% 9.0% —
Net Profit + -5 -5 -19 -4 25 32 29 32
EPS in Rs -1 -1 -4 -1 5 6 5 6
Dividend Payout % 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% —
Sales growth — -38 48 18 20 24 16 13

Source: Screener.in — figures in ₹ Crores unless marked %.

Balance Sheet

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026 Sep 2026
Reserves 37 33 9 6 31 198 232 254
Borrowings + 37 39 50 50 61 20 13 15
Other Liabilities + 31 34 43 40 46 60 40 36
Total Liabilities 106 106 103 97 139 288 297 316
Fixed Assets + 39 42 40 40 46 51 63 74
CWIP 0 7 0 0 0 0 0 0
Investments 0 0 0 0 6 10 27 35
Other Assets + 66 56 63 56 87 227 207 207
Total Assets 106 106 103 97 139 288 297 316
Equity Capital 0 0 0 0 0 11 11 11

Source: Screener.in — figures in ₹ Crores unless marked %.

Cash Flow

  Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cash from Operating Activity + 12 10 -2 14 8 44 -5
Cash from Investing Activity + -18 -9 3 -10 -11 -29 -78
Cash from Financing Activity + 6 0 -4 -1 -3 111 -18
Net Cash Flow 0 0 -3 3 -5 125 -101
Free Cash Flow -5 0 0 5 -5 28 -23
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 357 226 -30 157 38 109 4

Source: Screener.in — figures in ₹ Crores unless marked %.

Shareholding Pattern

Quarter-by-quarter — Promoters, FII, DII & public holding trend

Promoter holding: 41.7% → 41.75%
  Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026 Jun 2026 Sep 2026
Public 11.19% 10.39% 14.05% 15.01% 16.5% 17.21% 41.0%
Promoters 41.7% 41.7% 41.7% 41.7% 41.77% 41.8% 41.75%
FII 34.24% 33.59% 32.39% 32.45% 31.2% 30.1% 6.57%
DII 12.86% 14.3% 11.85% 10.82% 10.52% 10.89% 10.68%

Source: Screener.in — quarterly shareholding disclosures.

Peers Comparison

Healthcare — ranked by market cap

Company Market Cap (Cr) P/E P/B ROE
Laxmi Dental Limited (this stock) 1,076 29.7 4.05 14.8%
Sigachi Industries Ltd 1,088 41.3 2.02 5.78%
Lincoln Pharma Ltd 1,032 10.6 1.27 12.0%
Bafna Pharmaceuticals Ltd 1,121 — 2.19 -6.18%
Gpt Healthcare Limited 1,136 27.3 — 28.5%
3b Blackbio Dx Ltd. 1,157 19.7 3.33 19.8%
Themis Medicare Ltd. 929 624.0 2.33 0.41%

Which Mutual Funds Hold Laxmi Dental Limited?

Frequently Asked Questions about Laxmi Dental Limited

Community Sentiment

What are other investors saying about Laxmi Dental Limited?

No votes yet — be the first to share your view.

Sign in to vote

Discussion

User-generated content — not investment advice, and not verified or endorsed by TopFund.

Sign in to join the discussion

No comments yet — start the discussion.